| Print
EVOTEC SE INH O.N. (EVT)
Inhaber-Aktien o.N.This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000employees and 18 production sites mainly in Europe and the United States.
Address
Manfred Eigen Campus
Essener Bogen 7
Hamburg
DEU
22419
Telephone
+49 040 56081286
Forecast key dates
| Name | Key Date |
|---|---|
| Evotec SE Third Quarter Earnings Conference Call for 2026 | 2026-11-05T08:00:00 |
| Evotec SE Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Evotec SE Second Quarter Earnings Conference Call for 2026 | 2026-08-13T08:00:00 |
| Evotec SE Second Quarter Earnings Results for 2026 | 2026-08-13T00:00:00 |
| Evotec SE Annual General Meeting for 2026 | 2026-06-03T10:00:00 |
| Evotec SE First Quarter Earnings Conference Call for 2026 | 2026-05-06T14:00:00 |
| Evotec SE First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
| Evotec SE Fourth Quarter Earnings Conference Call for 2025 | 2026-04-17T08:00:00 |
| Evotec SE Fourth Quarter Earnings Results for 2025 | 2026-04-17T00:00:00 |
| Evotec SE Annual Report for 2025 | 2026-04-16T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Evotec SE Third Quarter Earnings Conference Call for 2025 | 2025-11-05T08:00:00 |
| Evotec SE Third Quarter Earnings Result for 2025 | 2025-11-05T00:00:00 |
| Evotec SE Second Quarter Earnings Conference Call for 2025 | 2025-08-13T08:00:00 |
| Evotec SE Second Quarter Earnings Result for 2025 | 2025-08-13T00:00:00 |
| Evotec SE Annual General Meeting for 2025 | 2025-06-03T10:00:00 |
| Evotec SE First Quarter Earnings Conference Call for 2025 | 2025-05-06T14:00:00 |
| Evotec SE First Quarter Earnings Result for 2025 | 2025-05-06T00:00:00 |
| Evotec SE Fourth Quarter Earnings Conference Call for 2024 | 2025-04-17T08:00:00 |
| Evotec SE Fourth Quarter Earnings Result for 2024 | 2025-04-17T00:00:00 |
| Evotec SE Annual Report for 2024 | 2025-04-16T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.